BRD: take control
Take control of your cattle¹s health, and reduce bovine respiratory disease costs.
Bovine respiratory disease (BRD) can be a costly expense for cattle producers, however, it¹s an expense that can be avoided. BRD is one of the most common and costly diseases affecting the United States cattle industry. In fact, the U.S. feedlot industry estimates an annual loss as high as $1 billion due to loss of production, increased labor expenses, pharmaceutical costs and death deriving from BRD.1,2 The loss of an animal, decreased average daily gain and cost of treatment quickly can put a dent in a producer¹s pocket.
³If cattle are treated more than once, they never get back to that peak performance,² said Shawn Blood, DVM, Beef Strategic Technical Services Team, Zoetis. ³The weight loss that animal has due to BRD sickness will stay with them throughout the feeding period.²
BRD refers to any disease of the lower or upper respiratory tracts in cattle and is commonly associated with lung infections, which can cause pneumonia. It¹s a complex disease caused by a variety of factors, including:
· Host factors (animal age, immunity, genetics, exposure to pathogens)
· Environmental factors (crowding, temperature, commingling, transport)
· Internal or external parasite infections
· Infectious agents:
o Viruses, including: bovine parainfluenza virus (PI3), infectious bovine rhinotracheitis (IBR), bovine respiratory syncytial virus (BRSV), bovine viral diarrhea (BVD) virus and bovine coronavirus (BCV)
o Pathogens, including: Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis
To help reduce losses from BRD, it is important for producers to control BRD before it hits their operation. As a first step, Dr. Blood recommends a broad-spectrum antimicrobial like DRAXXIN® (tulathromycin) Injectable Solution as part of an effective BRD control program.
³Without the ability to do rapid animal-side testing to differentiate which bacterial pathogen is in those animals, we rely on a broader antimicrobial that is effective against all of the four main pathogens,² Dr. Blood said.
When selecting an antimicrobial to help manage BRD, it is important to select based on efficacy and sound science. Dr. Blood recently helped complete a retrospective review of 12 studies that examined the BRD first-treatment success following metaphylaxis with DRAXXIN in high-risk stocker and feedlot cattle.
In all 12 studies when DRAXXIN was the metaphylactic antimicrobial, there were higher demonstrated BRD first-treatment success rates when an animal was pulled for treatment. Overall, DRAXXIN delivered up to a 22.4% first-treatment success advantage when compared with other metaphylactic antimicrobials.3-12
³The review included all references found in North American studies,² Dr. Blood said. ³It¹s tough to find a product that shows the best response in 12 studies like that. If the product works right the first time, there is no need for another treatment, which saves the producer money and is better for the animal.²
An effective metaphylactic product on arrival is just one important part of an overall BRD management program. Dr. Blood encourages producers to work closely with their veterinarian to develop a complete BRD management program.
For more information and to learn more about effective BRD control, visit DRAXXIN.com.
IMPORTANT SAFETY INFORMATION: DRAXXIN has a pre-slaughter withdrawal time of 18 days. Do not use in female dairy cattle 20 months of age or older. Do not use in animals known to be hypersensitive to the product. See full Prescribing Information at draxxin.com/PI.
Start a dialogue, stay on topic and be civil.
If you don't follow the rules, your comment may be deleted.
User Legend: Moderator Trusted User